During a two-hour experimental chat with a therapist chatbot character, it “actively encouraged me to disregard my ...
Most Medicare enrollees will face premiums that are 10% higher next year, creating budget anxiety for millions of seniors.
The deals keeps coming. Merck this morning said it will acquire Cidara Therapeutics, the maker of an experimental flu therapy ...
The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...
A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma’s latest deal to settle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback